119 related articles for article (PubMed ID: 15173004)
1. Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies.
He X; Brenchley PE; Jayson GC; Hampson L; Davies J; Hampson IN
Cancer Res; 2004 Jun; 64(11):3928-33. PubMed ID: 15173004
[TBL] [Abstract][Full Text] [Related]
2. [Effects of anti-heparanase antibody on the growth and invasion of HCCLM6 human hepatocellular carcinoma cells].
Han XM; Wang HJ; Yang JM; Zhou YL; Tao HQ; Gao H; Ye ZY
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):10-4. PubMed ID: 19538861
[TBL] [Abstract][Full Text] [Related]
3. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13].
Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ
Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787
[TBL] [Abstract][Full Text] [Related]
5. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.
Goldshmidt O; Zcharia E; Abramovitch R; Metzger S; Aingorn H; Friedmann Y; Schirrmacher V; Mitrani E; Vlodavsky I
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10031-6. PubMed ID: 12097647
[TBL] [Abstract][Full Text] [Related]
6. Processing and activation of latent heparanase occurs in lysosomes.
Zetser A; Levy-Adam F; Kaplan V; Gingis-Velitski S; Bashenko Y; Schubert S; Flugelman MY; Vlodavsky I; Ilan N
J Cell Sci; 2004 May; 117(Pt 11):2249-58. PubMed ID: 15126626
[TBL] [Abstract][Full Text] [Related]
7. Heparanase affects adhesive and tumorigenic potential of human glioma cells.
Zetser A; Bashenko Y; Miao HQ; Vlodavsky I; Ilan N
Cancer Res; 2003 Nov; 63(22):7733-41. PubMed ID: 14633698
[TBL] [Abstract][Full Text] [Related]
8. Function of heparanase in prostate tumorigenesis: potential for therapy.
Lerner I; Baraz L; Pikarsky E; Meirovitz A; Edovitsky E; Peretz T; Vlodavsky I; Elkin M
Clin Cancer Res; 2008 Feb; 14(3):668-76. PubMed ID: 18212251
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
10. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of invasiveness of human mammary carcinoma cell line MDA435 by heparanase antisense oligodeoxynucleotide].
Zhang YL; Fu ZR; Zhang J; Wang YH; Shen Q
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):204-7. PubMed ID: 12812662
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypoxia and re-oxygenation on cell invasion and adhesion in human ovarian carcinoma cells.
Shi J; Wan Y; Di W
Oncol Rep; 2008 Oct; 20(4):803-7. PubMed ID: 18813821
[TBL] [Abstract][Full Text] [Related]
13. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
Xuan JA; Schneider D; Toy P; Lin R; Newton A; Zhu Y; Finster S; Vogel D; Mintzer B; Dinter H; Light D; Parry R; Polokoff M; Whitlow M; Wu Q; Parry G
Cancer Res; 2006 Apr; 66(7):3611-9. PubMed ID: 16585186
[TBL] [Abstract][Full Text] [Related]
14. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.
Davidson B; Shafat I; Risberg B; Ilan N; Trope' CG; Vlodavsky I; Reich R
Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350
[TBL] [Abstract][Full Text] [Related]
15. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
[TBL] [Abstract][Full Text] [Related]
16. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
Aucoin R; Reiland J; Roy M; Marchetti D
J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
[TBL] [Abstract][Full Text] [Related]
17. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of siRNA on heparanase expression and invasion ability of gastric cancer cells: an in vitro experiment].
Zhang Y; Wang ZN; Zhang X; Xu HM; Jiang L; Luo Y; Xing LL; Xu MD; Li J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1717-20. PubMed ID: 17825158
[TBL] [Abstract][Full Text] [Related]
19. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.
Zhang Y; Li L; Wang Y; Zhang J; Wei G; Sun Y; Shen F
Biochem Biophys Res Commun; 2007 Jun; 358(1):124-9. PubMed ID: 17467664
[TBL] [Abstract][Full Text] [Related]
20. Involvement of disulfide bond formation in the activation of heparanase.
Simizu S; Suzuki T; Muroi M; Lai NS; Takagi S; Dohmae N; Osada H
Cancer Res; 2007 Aug; 67(16):7841-9. PubMed ID: 17699790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
